{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:49:45Z","timestamp":1789264185759,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["2016YFC0901500"],"award-info":[{"award-number":["2016YFC0901500"]}]},{"name":"CAMS Innovation Fund for Medical Science","award":["2017-I2M-3-001"],"award-info":[{"award-number":["2017-I2M-3-001"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771757"],"award-info":[{"award-number":["81771757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571587"],"award-info":[{"award-number":["81571587"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601433"],"award-info":[{"award-number":["81601433"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis\/periaortitis and periarteritis (PAO\/PA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study prospectively enrolled 587 patients with IgG4-RD with a follow-up time of more than 6\u2009months. The distribution of IgG4-related PAO\/PA was classified into four types: type 1, thoracic aorta; type 2a, abdominal aorta; type 2b, abdominal aorta and iliac artery; type 2c, iliac artery; type 3, thoracic and abdominal aorta; and type 4, other arteries. Patient\u2019s demographic data, clinical characteristics, laboratory parameters, and treatment efficacy were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 587 IgG4-RD patients, 89 (15.2%) had PAO\/PA. The average age was 58.3\u2009\u00b1\u200911.1\u2009years, with male predominance (85.4%). Vessels affected were as follows: abdominal aorta (83.1%), iliac artery (70.8%), thoracic aorta (13.5%), and other vessels (13.5%). The most prevalent distribution type of IgG4-related PAO\/PA was type 2b, with 74 (83.1%) patients, followed by type 2a, type 2c, type 3, and type 1. Fifty-five (61.8%) PAO\/PA patients had hydronephrosis, with renal insufficiency occurring in 43 (48.3%), and 31 (34.8%) PAO\/PA patients had D-J stent drainage due to severe ureteral obstruction. After treatment with a glucocorticoid and immunosuppressants, 82% patients achieved remission with shrinking of the perivascular mass by more than 30%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>IgG4-RD with PAO\/PA was distinct from non-PAO\/PA in demographic features, organ involvement distribution, inflammatory markers, and serum IgG4 and IgE. The most common affected vessel was the abdominal aorta, and most patients responded well with treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02197-w","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T07:02:57Z","timestamp":1588575777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["IgG4-related aortitis\/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Linyi","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-9867","authenticated-orcid":false,"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"2197_CR1","doi-asserted-by":"crossref","unstructured":"Shiokawa M, Kodama Y, Sekiguchi K, et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med. 2018;10(453):eaaq0997.","DOI":"10.1126\/scitranslmed.aaq0997"},{"issue":"4","key":"2197_CR2","first-page":"728","volume":"67","author":"LM Hubers","year":"2018","unstructured":"Hubers LM, Vos H, Schuurman AR, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut. 2018;67(4):728\u201335.","journal-title":"Gut."},{"key":"2197_CR3","doi-asserted-by":"crossref","unstructured":"Martin-Nares E, Angeles-Angeles A, Hernandez-Molina G. Major salivary gland enlargement in IgG4-related disease is associated with multiorgan involvement and higher basal disease activity. Mod Rheumatol. 2020;30:172-7.","DOI":"10.1080\/14397595.2019.1572575"},{"issue":"9","key":"2197_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392.","journal-title":"Mod Pathol"},{"issue":"1","key":"2197_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13075-017-1432-8","volume":"19","author":"M Ozawa","year":"2017","unstructured":"Ozawa M, Fujinaga Y, Asano J, et al. Clinical features of IgG4-related periaortitis\/periarteritis based on the analysis of 179 patients with IgG4-related disease: a case-control study. Arthritis Res Ther. 2017;19(1):223.","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"2197_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","volume":"78","author":"ZS Wallace","year":"2019","unstructured":"Wallace ZS, Zhang Y, Perugino CA, et al. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019;78(3):406\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2197_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13075-019-1828-8","volume":"21","author":"M Wang","year":"2019","unstructured":"Wang M, Zhang P, Lin W, et al. Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy. Arthritis Res Ther. 2019;21(1):44.","journal-title":"Arthritis Res Ther."},{"issue":"9976","key":"2197_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015;385(9976):1460\u201371.","journal-title":"Lancet."},{"issue":"11","key":"2197_CR9","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1093\/rheumatology\/kev225","volume":"54","author":"A Palmisano","year":"2015","unstructured":"Palmisano A, Urban ML, Corradi D, et al. Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? Rheumatology (Oxford). 2015;54(11):2004\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"28","key":"2197_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003344","volume":"95","author":"CA Perugino","year":"2016","unstructured":"Perugino CA, Wallace ZS, Meyersohn N, et al. Large vessel involvement by IgG4-related disease. Medicine. 2016;95(28):e3344.","journal-title":"Medicine."},{"issue":"1","key":"2197_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/BOR.0b013e3283412f7c","volume":"23","author":"JR Stone","year":"2011","unstructured":"Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23(1):88\u201394.","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"2197_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/rheumatology\/keu462","volume":"54","author":"T Castelein","year":"2015","unstructured":"Castelein T, Coudyzer W, Blockmans D. IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis? Rheumatology (Oxford). 2015;54(7):1250\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"2197_CR13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1111\/1756-185X.13194","volume":"20","author":"IY Kim","year":"2017","unstructured":"Kim IY, Eun YH, Jeong H, et al. Clinical characteristics and outcomes of 61 patients with chronic periaortitis including IgG4-related and non-IgG4-related cases. Int J Rheum Dis. 2017;20(11):1751\u201362.","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"2197_CR14","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/art.38032","volume":"65","author":"A Vaglio","year":"2013","unstructured":"Vaglio A, Catanoso MG, Spaggiari L, et al. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. 2013;65(9):2469\u201375.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2197_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22(1):21\u201330.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"2197_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","volume":"27","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazaki K, Nakamura T, et al. Current approach to the diagnosis of IgG4-related disease - combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol. 2017;27(3):381\u201391.","journal-title":"Mod Rheumatol"},{"issue":"24","key":"2197_CR17","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1161\/CIRCULATIONAHA.110.014902","volume":"123","author":"A Schanzer","year":"2011","unstructured":"Schanzer A, Greenberg RK, Hevelone N, et al. Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair. Circulation. 2011;123(24):2848\u201355.","journal-title":"Circulation."},{"issue":"1","key":"2197_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1024\/0301-1526\/a000491","volume":"45","author":"L Caspary","year":"2016","unstructured":"Caspary L. Inflammatory diseases of the aorta. VASA. 2016;45(1):17\u201329.","journal-title":"VASA."},{"issue":"2","key":"2197_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","volume":"39","author":"PJ Scheel Jr","year":"2013","unstructured":"Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis. Rheum Dis Clin N Am. 2013;39(2):365\u201381.","journal-title":"Rheum Dis Clin N Am"},{"issue":"11","key":"2197_CR20","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.23543","volume":"70","author":"ZS Wallace","year":"2018","unstructured":"Wallace ZS, Khosroshahi A, Carruthers MD, et al. An international multispecialty validation study of the IgG4-related disease responder index. Arthritis Care Res. 2018;70(11):1671\u20138.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"2197_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol. 2016;45(2):135\u201345.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"2197_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/rheumatology\/key227","volume":"58","author":"F Yunyun","year":"2019","unstructured":"Yunyun F, Yu P, Panpan Z, et al. Efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Rheumatology (Oxford). 2019;58(1):52\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2197_CR23","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.autrev.2014.08.013","volume":"13","author":"P Brito-Zeron","year":"2014","unstructured":"Brito-Zeron P, Ramos-Casals M, Bosch X, et al. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13(12):1203\u201310.","journal-title":"Autoimmun Rev"},{"key":"2197_CR24","doi-asserted-by":"crossref","unstructured":"Tomelleri A, Campochiaro C, Sartorelli S, et al. Gender differences in clinical presentation and vascular pattern in patients with Takayasu arteritis. Scand J Rheumatol. 2019;48:482-90.","DOI":"10.1080\/03009742.2019.1581838"},{"issue":"10","key":"2197_CR25","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s00380-017-0987-2","volume":"32","author":"H Yamamoto","year":"2017","unstructured":"Yamamoto H, Sugiyama E, Serikawa M, et al. Clinical features and predictive value of serum inflammatory markers of perivascular involvement in immunoglobulin G4-related disease. Heart Vessel. 2017;32(10):1176\u201385.","journal-title":"Heart Vessel"},{"issue":"4","key":"2197_CR26","doi-asserted-by":"publisher","first-page":"R156","DOI":"10.1186\/ar4671","volume":"16","author":"I Mizushima","year":"2014","unstructured":"Mizushima I, Inoue D, Yamamoto M, et al. Clinical course after corticosteroid therapy in IgG4-related aortitis\/periaortitis and periarteritis: a retrospective multicenter study. Arthritis Res Ther. 2014;16(4):R156.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2197_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/14397595.2018.1546367","volume":"29","author":"I Mizushima","year":"2019","unstructured":"Mizushima I, Kasashima S, Fujinaga Y, Kawano M, Ishizaka N. IgG4-related periaortitis\/periarteritis: an under-recognized condition that is potentially life-threatening. Mod Rheumatol. 2019;29(2):240\u201350.","journal-title":"Mod Rheumatol"},{"issue":"12","key":"2197_CR28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00380-018-1203-8","volume":"33","author":"S Kasashima","year":"2018","unstructured":"Kasashima S, Kawashima A, Kasashima F, Endo M, Matsumoto Y, Kawakami K. Inflammatory features, including symptoms, increased serum interleukin-6, and C-reactive protein, in IgG4-related vascular diseases. Heart Vessel. 2018;33(12):1471\u201381.","journal-title":"Heart Vessel"},{"issue":"5","key":"2197_CR29","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/rheumatology\/kex333","volume":"57","author":"G Keser","year":"2018","unstructured":"Keser G, Aksu K, Direskeneli H. Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited. Rheumatology (Oxford). 2018;57(5):784\u201390.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2197_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13075-018-1567-2","volume":"20","author":"L Wang","year":"2018","unstructured":"Wang L, Zhang P, Wang M, et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018;20(1):65.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"2197_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74(1):190\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2197_CR32","first-page":"25","volume":"19","author":"W Lin","year":"2017","unstructured":"Lin W, Zhang P, Chen H, et al. Circulating plasmablasts\/plasma cells: a potential biomarker for IgG4-related disease. Ann Rheum Dis. 2017;19(1):25.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2197_CR33","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cgh.2017.02.007","volume":"15","author":"EL Culver","year":"2017","unstructured":"Culver EL, Sadler R, Bateman AC, et al. Increases in IgE, eosinophils, and mast cells can be used in diagnosis and to predict relapse of IgG4-related disease. Clin Gastroenterol Hepatol. 2017;15(9):1444\u201352 e6.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"12","key":"2197_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11926-018-0789-2","volume":"20","author":"A Palmisano","year":"2018","unstructured":"Palmisano A, Maritati F, Vaglio A. Chronic periaortitis: an update. Curr Rheumatol Rep. 2018;20(12):80.","journal-title":"Curr Rheumatol Rep"},{"key":"2197_CR35","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1016\/S2665-9913(19)30017-7","volume":"1","author":"W Zhang","year":"2019","unstructured":"Zhang W, Stone JH. Management of IgG4-related disease. Lancet Rheumatol. 2019;1:e55\u201365.","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"2197_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/annrheumdis-2011-200148","volume":"71","author":"M Binder","year":"2012","unstructured":"Binder M, Uhl M, Wiech T, et al. Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitis. Ann Rheum Dis. 2012;71(2):311\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2197_CR37","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","volume":"7","author":"F Yunyun","year":"2017","unstructured":"Yunyun F, Yu C, Panpan Z, et al. Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep. 2017;7(1):6195.","journal-title":"Sci Rep"},{"issue":"3","key":"2197_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11739-016-1599-z","volume":"12","author":"GM Rossi","year":"2017","unstructured":"Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med. 2017;12(3):287\u201399.","journal-title":"Intern Emerg Med"},{"key":"2197_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.humpath.2013.07.035","volume":"45","author":"M Tajima","year":"2014","unstructured":"Tajima M, Hiroi Y, Takazawa Y, Muraoka H, Iwata H, Yamashita H, et al. Immunoglobulin G4-related multiple systemic aneurysms and splenic aneurysm rupture during steroid therapy. Hum Pathol. 2014;45:175\u20139.","journal-title":"Hum Pathol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02197-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02197-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02197-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T19:42:05Z","timestamp":1620070925000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02197-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02197-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16955\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16955\/v2","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"6 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Peking Union Medical College Hospital. All patients consented to this study and signed a written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Yes, we obtained consent for publication from all authors in the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"103"}}